Trial Information
Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome
Inclusion Criteria:
- Patients with MDS (1)intermediate-2 or high risk (2)low or intermediate-1 risk with
drug resistance or disease progression
- without identical sibling donor
Exclusion Criteria:
- Contraindication to HSCT
- Pregnancy
- Mental illness
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
survival rate
Outcome Description:
number of participants with survival at one year
Outcome Time Frame:
participants will be followed for an expected average of one year
Safety Issue:
No
Principal Investigator
xiaojun huang, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Peking University People's Hospital
Authority:
China: Ministry of Health
Study ID:
PUPH IRB [2013] (04)
NCT ID:
NCT01793675
Start Date:
April 2003
Completion Date:
December 2014
Related Keywords:
- Advanced MDS Without Identical Sibling Donor
- Myelodysplastic Syndromes
- Preleukemia